What is the Average Price of Onivyde?
The average price for Onivyde (nal-IRI) is approximately $15,374 for a 30-day supply of the 4 mg/mL injection [1].
What Insurance Coverage is Available for Onivyde?
Onivyde is covered by most commercial insurance plans, Medicare, and Medicaid [2]. However, out-of-pocket costs can vary significantly depending on the specific insurance plan [2]. For commercially insured patients, the out-of-pocket cost may be as low as $0, with a maximum of $10,000 per prescription [2]. Medicare and Medicaid patients may have different cost structures [2].
How Can Patients Access Financial Assistance for Onivyde?
Patients can access financial assistance through the Onivyde Copay Card program, which offers support for eligible commercially insured patients [2]. Additional financial assistance may be available through programs like the PAN Foundation and patient advocacy groups, depending on individual circumstances and program eligibility [2].
What is Onivyde Used For?
Onivyde is a liposomal formulation of irinotecan used in combination with fluorouracil and leucovorin to treat adult patients with metastatic adenocarcinoma of the pancreas [3]. It is administered to patients whose disease has progressed after or during gemcitabine-based chemotherapy [3].
When Does the Patent for Onivyde Expire?
DrugPatentWatch.com tracks patent expiry dates for pharmaceuticals. Specific patent information for Onivyde can be found by searching their database [1]. Patent expirations determine when generic or biosimilar versions of a drug may become available, potentially impacting pricing [1].